Comments
Loading...

Acurx Pharmaceuticals

ACXPNASDAQ
Logo brought to you by Benzinga Data
$1.45
0.064.29%
Pre-Market: 8:25 AM EDT

Acurx Pharmaceuticals (NASDAQ:ACXP) Stock, Earnings Estimates, EPS, And Revenue

Acurx Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 12
EPS
$-0.170
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Acurx Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Acurx Pharmaceuticals (ACXP) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-12$-0.17$-0.2015.0 %
Jun 20242024-08-09$-0.26$-0.22-18.2 %
Mar 20242024-05-14$-0.28$-0.24-16.7 %
Dec 20232024-03-18$-0.37$-0.26-42.3 %

Acurx Pharmaceuticals (ACXP) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?

A

Acurx Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Acurx Pharmaceuticals (NASDAQ:ACXP)?

A

Acurx Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-0.17, which beat the estimate of $-0.20.

Q

What were Acurx Pharmaceuticals’s (NASDAQ:ACXP) revenues?

A

Acurx Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch